Placebo to glargine

BIOLOGICAL2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Type 1 Diabetes MellitusType 2 Diabetes Mellitus

Phase 1

Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002)

CompletedNCT03095651

Merck Sharp & Dohme LLCType 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Start: 2017-04-12End: 2018-01-30Updated: 2019-04-01

Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001)

CompletedNCT03170544

Merck Sharp & Dohme LLCType 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Start: 2017-08-16End: 2018-11-08Updated: 2019-11-15

Related Papers

A Randomized, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Insulin Dimer

Clinical Pharmacology & Therapeutics2022-04-071 citations